Journal of Clinical Endocrinology & Metabolism, Vol 81, 321-326, Copyright © 1996 by Endocrine Society

ARTICLES

Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency

CE Fardella, DW Hum, H Rodriguez, G Zhang, FL Barry, A Ilicki, CA Bloch and WL Miller
Department of Pediatrics, University of California, San Francisco 94143- 0978, USA.

Cytochrome P450c11AS (aldosterone synthase) has 11 beta-hydroxylase, 18- hydroxylase, and 18-oxidase activities and is expressed solely in the adrenal zona glomerulosa. Corticosterone methyloxidase II (CMOII) deficiency denotes a rare disorder of adrenal steroidogenesis in which only the 18-oxidase activity of P450c11AS is disrupted, while the 11 beta-hydroxylase and 18-hydroxylase activities persist. Such patients have elevated serum concentrations of corticosterone and 18- hydroxycorticosterone and very low or unmeasurable concentrations of aldosterone, often resulting in a clinical salt-losing crisis in infancy. One pair of point mutations, Arg181-->Trp and Val386-->Ala, has been previously characterized to cause this disorder in an inbred Iranian Jewish population. We have sought mutations causing CMOII deficiency in outbred populations. In three of four unrelated P450c11AS alleles from two unrelated patients with CMOII deficiency, we found a gene conversion event in which exons 3 and 4 of the CYP11B2 gene encoding P450c11AS were changed to the sequence of the nearby CYP11B1 gene, which encodes the related enzyme P450c11 beta. This conversion resulted in a mutant P450c11AS protein carrying three changes: Asp141-- >Glu, Lys151-->Asn, and Ile246-->Thr. We built seven vectors expressing P450c11AS carrying each mutation singly, each of the three possible pairs of mutations, and the triple mutation as found in the proband. The activities of both the normal P450c11AS and the various mutants in transfected nonsteroidogenic COS-1 cells were very low, but their activities in steroidogenic MA-10 and JEG-3 cells were 10- to 20-fold higher. In these systems all of the mutants retained normal 18-oxidase activity, indicating that the detected gene conversion event is associated with but does not cause CMOII deficiency. None of the four CYP11B2 alleles in these two patients bore other identifiable mutations. These patients might have mutations in the promoters or other noncoding regions, or mutations in genes other than CYP11B2 may cause the syndrome of CMOII deficiency.

This article has been cited by other articles:

				J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function Endocr. Rev., April 1, 2008; 29(2): 133 - 154. [Abstract] [Full Text] [PDF]

				M. Barr, S. M. MacKenzie, E. C. Friel, C. D. Holloway, D. M. Wilkinson, N. J.R. Brain, M. C. Ingram, R. Fraser, M. Brown, N. J. Samani, et al. Polymorphic Variation in the 11{beta}-Hydroxylase Gene Associates With Reduced 11-Hydroxylase Efficiency Hypertension, January 1, 2007; 49(1): 113 - 119. [Abstract] [Full Text] [PDF]

				X. Wang, M. Y. H. Zhang, W. L. Miller, and A. A. Portale Novel Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency That Confer Partial Enzyme Activity in Vitro J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2424 - 2430. [Abstract] [Full Text] [PDF]

				K. M. Kayes-Wandover, G. M. Tannin, D. Shulman, D. Peled, K. L. Jones, L. Karaviti, and P. C. White Congenital Hyperreninemic Hypoaldosteronism Unlinked to the Aldosterone Synthase (CYP11B2) Gene J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5379 - 5382. [Abstract] [Full Text] [PDF]

				C. E. Fardella, M. Pinto, L. Mosso, C. Gomez-Sanchez, J. Jalil, and J. Montero Genetic Study of Patients with Dexamethasone-Suppressible Aldosteronism without the Chimeric CYP11B1/CYP11B2 Gene J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4805 - 4807. [Abstract] [Full Text] [PDF]

				K. M. Kayes-Wandover, R. E. L. Schindler, H. C. Taylor, and P. C. White Type 1 Aldosterone Synthase Deficiency Presenting in a Middle-Aged Man J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1008 - 1012. [Abstract] [Full Text]

				A. Fisher, R. Fraser, J. MC Connell, and E. Davies Amino Acid Residue 147 of Human Aldosterone Synthase and 11{beta}-Hydroxylase Plays a Key Role in 11{beta}-Hydroxylation J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1261 - 1266. [Abstract] [Full Text]

				P. Mulatero, K. M. Curnow, B. Aupetit-Faisant, M. Foekling, C. Gomez-Sanchez, F. Veglio, X. Jeunemaitre, P. Corvol, and L. Pascoe Recombinant CYP11B Genes Encode Enzymes that Can Catalyze Conversion of 11-Deoxycortisol to Cortisol, 18-Hydroxycortisol, and 18-Oxocortisol J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3996 - 4001. [Abstract] [Full Text]

				S. Portrat-Doyen, J. Tourniaire, O. Richard, P. Mulatero, B. Aupetit-Faisant, K.M. Curnow, L. Pascoe, and Y. Morel Isolated Aldosterone Synthase Deficiency Caused by Simultaneous E198D and V386A Mutations in the CYP11B2 Gene J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4156 - 4161. [Abstract] [Full Text]

				D. P. Merke, T. Tajima, A. Chhabra, K. Barnes, E. Mancilla, J. Baron, and G. B. Cutler Jr. Novel CYP11B1 Mutations in Congenital Adrenal Hyperplasia due to Steroid 11{beta}-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 270 - 273. [Abstract] [Full Text]

				G. K. Fu, D. Lin, M. Y. H. Zhang, D. D. Bikle, C. H. L. Shackleton, W. L. Miller, and A. A. Portale Cloning of Human 25-Hydroxyvitamin D-1{alpha}-Hydroxylase and Mutations Causing Vitamin D-Dependent Rickets Type 1 Mol. Endocrinol., December 1, 1997; 11(13): 1961 - 1970. [Abstract] [Full Text] [PDF]

				M. Peter, L. Fawaz, S. L. S. Drop, H. K. A. Visser, and W. G. Sippell Hereditary Defect in Biosynthesis of Aldosterone: Aldosterone Synthase Deficiency 1964-1997 J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3525 - 3528. [Abstract] [Full Text] [PDF]